An Air France flight from Paris to Detroit diverted to Montreal on Wednesday, May 20, after U.S. authorities cited Ebola travel restrictions [2].
The incident highlights the strict protocols maintained by U.S. border agencies to prevent the entry of travelers from Ebola-affected regions. Because the U.S. prohibits entry for individuals who have recently visited such areas, the aircraft was rerouted to Canada to avoid a breach of these health regulations [1, 3].
One passenger was identified as a potential exposure risk due to recent travel in the Democratic Republic of Congo [1]. The aircraft departed from Charles-de-Gaulle Airport in Paris and was originally bound for Detroit before landing at Montreal-Trudeau Airport [1, 2].
Canadian officials conducted a screening of the individual upon arrival. A Public Health Agency of Canada official said the individual was screened, found to be asymptomatic, and would be returned to Paris for further monitoring [3].
Canadian Border Services Agency officials coordinated the landing to comply with international health guidance. A spokesperson for the agency said, "We are following the U.S. guidance on Ebola-related travel restrictions and have taken the precautionary step of diverting the aircraft to Montreal" [2].
Medical experts have since downplayed the risk of the diversion leading to a local health crisis. Dr. Allison McGeer said the passenger is asymptomatic and does not pose a risk, and said they do not anticipate a substantial outbreak in Canada [1].
The passenger was subsequently sent back to Paris [1].
“The passenger is asymptomatic and does not pose a risk”
This event underscores the tension between international air travel and national health security. The decision by U.S. authorities to deny entry based on travel history—regardless of whether a passenger is symptomatic—forces third-party countries like Canada to act as intermediaries for screening and repatriation. It demonstrates that Ebola travel restrictions remain a high-priority trigger for aviation diversions to prevent potential viral introduction into the U.S. population.
